Cargando…

Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges

BACKGROUND: “Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cath...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreck, Benoit, Guerlais, Marylène, Laforgue, Edouard, Bichon, Célia, Grall-Bronnec, Marie, Victorri-Vigneau, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387686/
https://www.ncbi.nlm.nih.gov/pubmed/32792999
http://dx.doi.org/10.3389/fpsyt.2020.00705
_version_ 1783564176431513600
author Schreck, Benoit
Guerlais, Marylène
Laforgue, Edouard
Bichon, Célia
Grall-Bronnec, Marie
Victorri-Vigneau, Caroline
author_facet Schreck, Benoit
Guerlais, Marylène
Laforgue, Edouard
Bichon, Célia
Grall-Bronnec, Marie
Victorri-Vigneau, Caroline
author_sort Schreck, Benoit
collection PubMed
description BACKGROUND: “Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cathinones. METHODS: All spontaneous notifications (Nots) of slam practice reported between January 2012 and October 2019 at the Nantes addictovigilance center in France were collected and analyzed. The purpose of this work was to analyze cases of slam to characterize cathinone use disorder according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and to further our knowledge of slam practice based on data on drug use, risk taking and harmful consequences. RESULTS: We collected 39 slam Nots. The severity of cathinone use disorder was mild, moderate and severe for 18%, 12%, and 58% of the patients, respectively. “Much time spent using cathinone” was the diagnostic criterion most often cited (82%). CONCLUSIONS: To the best of our knowledge, our study is the first to evaluate the presence of a cathinone use disorder. Cathinone use disorder seems particularly important in this population of users, and negative consequences of slam practice appear quickly.
format Online
Article
Text
id pubmed-7387686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73876862020-08-12 Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges Schreck, Benoit Guerlais, Marylène Laforgue, Edouard Bichon, Célia Grall-Bronnec, Marie Victorri-Vigneau, Caroline Front Psychiatry Psychiatry BACKGROUND: “Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cathinones. METHODS: All spontaneous notifications (Nots) of slam practice reported between January 2012 and October 2019 at the Nantes addictovigilance center in France were collected and analyzed. The purpose of this work was to analyze cases of slam to characterize cathinone use disorder according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and to further our knowledge of slam practice based on data on drug use, risk taking and harmful consequences. RESULTS: We collected 39 slam Nots. The severity of cathinone use disorder was mild, moderate and severe for 18%, 12%, and 58% of the patients, respectively. “Much time spent using cathinone” was the diagnostic criterion most often cited (82%). CONCLUSIONS: To the best of our knowledge, our study is the first to evaluate the presence of a cathinone use disorder. Cathinone use disorder seems particularly important in this population of users, and negative consequences of slam practice appear quickly. Frontiers Media S.A. 2020-07-22 /pmc/articles/PMC7387686/ /pubmed/32792999 http://dx.doi.org/10.3389/fpsyt.2020.00705 Text en Copyright © 2020 Schreck, Guerlais, Laforgue, Bichon, Grall-Bronnec and Victorri-Vigneau http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Schreck, Benoit
Guerlais, Marylène
Laforgue, Edouard
Bichon, Célia
Grall-Bronnec, Marie
Victorri-Vigneau, Caroline
Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
title Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
title_full Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
title_fullStr Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
title_full_unstemmed Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
title_short Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
title_sort cathinone use disorder in the context of slam practice: new pharmacological and clinical challenges
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387686/
https://www.ncbi.nlm.nih.gov/pubmed/32792999
http://dx.doi.org/10.3389/fpsyt.2020.00705
work_keys_str_mv AT schreckbenoit cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges
AT guerlaismarylene cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges
AT laforgueedouard cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges
AT bichoncelia cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges
AT grallbronnecmarie cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges
AT victorrivigneaucaroline cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges